Emerging treatment options for short bowel syndrome: potential role of teduglutide
Cheng T Tee1,2 Katharina Wallis1,3 Simon M Gabe1,41Lennard-Jones Intestinal Failure Unit, St Mark's Hospital and Academic Institute, Harrow, UK; 2Antigen Presentation Research Group, Imperial College London, Northwick Park and St Mark's Campus, Harrow, UK; 3West Hertfordshire...
Main Authors: | Gabe SM, Wallis K, Tee CT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-08-01
|
Series: | Clinical and Experimental Gastroenterology |
Online Access: | http://www.dovepress.com/emerging-treatment-options-for-short-bowel-syndrome-potential-role-of--a8109 |
Similar Items
-
Teduglutide therapy in a child with short bowel syndrome
by: Stojšić Mirjana, et al.
Published: (2023-01-01) -
Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome
by: Janine Büttner, et al.
Published: (2023-09-01) -
Evaluation of the Effectiveness of Teduglutide Treatment in Patients with Short Bowel Syndrome in Slovakia—Multicenter Real-World Study
by: Laura Gombošová, et al.
Published: (2024-02-01) -
Population pharmacokinetics and exposure‐response analyses of teduglutide in adult and pediatric patients with short bowel syndrome
by: Jean‐Francois Marier, et al.
Published: (2021-11-01) -
Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials
by: Ulrich-Frank Pape, et al.
Published: (2020-04-01)